MOLECULAR TARGETUniProt: CAC88866
CASP3
caspase 3
46 compounds · BiohacksAI corpus v20260307-01
46
compounds
Compounds
46
Gene Symbol
CASP3
NCBI Gene
836
Looking for compounds that interact with CASP3?
View all 46 compounds →About CASP3
CASP3 (caspase 3) is a biological target studied in biomedical research. The BiohacksAI corpus identifies 46 compounds with documented interactions with this target, based on BindingDB assay data and PubMed literature.
View CASP3 on UniProt →Compounds Targeting CASP3 (46)
1
Diacerein
2.77
confidence
2
Pralnacasan
2.08
confidence
297
studies
1.79
confidence
280
studies
1.61
confidence
297
studies
1.61
confidence
295
studies
1.39
confidence
300
studies
1.39
confidence
297
studies
1.10
confidence
300
studies
1.10
confidence
298
studies
1.10
confidence
300
studies
1.10
confidence
300
studies
1.10
confidence
300
studies
1.10
confidence
300
studies
1.10
confidence
35
studies
1.10
confidence
1000
studies
0.69
confidence
200
studies
0.69
confidence
298
studies
0.69
confidence
96
studies
0.69
confidence
300
studies
0.69
confidence
300
studies
0.69
confidence
299
studies
0.69
confidence
23
300
studies
0.69
confidence
270
studies
0.69
confidence
297
studies
0.69
confidence
300
studies
0.69
confidence
299
studies
0.69
confidence
299
studies
0.69
confidence
300
studies
0.69
confidence
292
studies
0.69
confidence
31
Ninhydrinpolycyclic
0
studies
0.69
confidence
215
studies
0.69
confidence
128
studies
0.69
confidence
298
studies
0.69
confidence
297
studies
0.69
confidence
36
Piceatannoldrugage
0
studies
0.69
confidence
121
studies
0.69
confidence
297
studies
0.69
confidence
300
studies
0.69
confidence
40
299
studies
0.69
confidence
41
300
studies
0.69
confidence
12
studies
0.69
confidence
1
studies
0.69
confidence
2
studies
0.69
confidence
2
studies
0.69
confidence
2
studies
0.69
confidence
Top 46 compounds by confidence score. Derived from BindingDB assay data.
Data Source
Corpusv20260307-01
SourceBindingDB · ChEMBL · PubMed
All data is computationally derived from published research. Not medical advice. Independent validation required.